Meet Our Supervising Physician and Co-founder: Dr. Michael Lafkas

Educational Background and Experience

Dr. Lafkas has been practicing medical aesthetics since 2004. He graduated from the University of California at Los Angeles with a BS in Biochemistry and then finished his Medical School training at the Keck School of Medicine of the University of Southern California in 1997 before completing his residency in Pediatrics at the Children's Hospital of Los Angeles.

Expertise in Neurotoxins and Dermal Fillers

Dr. Lafkas has been injecting neurotoxins and dermal fillers for over 20 years. He has been a speaker trainer for Allergan since 2006 and has instructed and trained hundreds of nurses in Botox and dermal filler injection technique. He has trained in both CME-accredited and non-accredited settings since 2006. Most recently, Dr. Lafkas was selected as one of the first injectors to administer the newest neurotoxin on the market, Daxxify.

Recognition in Medical Aesthetics

Having performed tens of thousands of treatments to date, Dr. Lafkas ranks among the busiest Botox and dermal filler injectors in Southern California. His practice has achieved a Top 10 in the Nation ranking by Allergan (out of over 40,000 accounts) which places it in the top 1/10th of 1% of Allergan accounts in the USA.

Leadership at Aluma Medical Aesthetics

As the co-founder and supervising physician of Aluma Medical Aesthetics, Dr. Lafkas demonstrates his commitment to advancing the field of medical aesthetics by empowering the top 1% of like-minded entrepreneurial injectors and supervising the growth of their individual practices.

As a key opinion leader, Dr. Lafkas works closely with the leading companies and executives in our industry including Abbvie/Allergan and Revance. Aluma Medical injectors have Dr. Lafkas at their disposal for any questions or concerns. They also benefit from his expert hands-on injection training, in addition to advice for growing their practice while maintaining a healthy work/life balance.

Check out Dr. Lafkas' Work

Check out his most recent study on the new neurotoxin, Daxxify

SPLIT FACE TRIAL

2 WEEK UPDATE

1 MONTH UPDATE

3 MONTH UPDATE

4 MONTH UPDATE (THE FINALE)